Thirty-seven strains of Pseudomonas cepacia from clinical, pharmaceutical-industrial, and environmental origins were analyzed for the presence of plasmid DNA by a modification of the rapid alkaline extraction method of Birnboim (H. C. Birnboim, Methods Enzymol. 100:243-255, 1983). Plasmids were present in 31 strains (84%) from all sources, with no one source showing less than 75% plasmid carriage among its strains. The plasmid profiles indicated that the presence of large plasmids (146 to 222 kb) was the norm. Those strains with greater antibiotic resistance were mainly in the clinical and pharmaceutical groups and carried large plasmids (222 kb) that appeared essentially identical by restriction digest analysis. The ability for conjugative transfer was shown with the broad-host-range plasmid R751 carrying the gene for resistance to trimethoprim, one of the few antimicrobial agents effective against P. cepacia. The plasmid was transferred from Pseudomonas aeruginosa to P. cepacia strains as well as from P. cepacia transconjugants to other P. cepacia strains.
Although originally described as a phytopathogen (3) , Pseudomonas cepacia is now best characterized by extreme resistance to antimicrobial agents (8) , metabolic diversity (22) , and the ability to survive and grow in purified waters (4) . These factors have led to the emergence of P. cepacia as a problem organism in health care product contamination (6, 7, 21) , nosocomial infections (5, 12, 18) , and recalcitrant infections of cystic fibrosis patients (19, 23, 24) .
There have been several reports describing plasmids from P. cepacia isolates of clinical or plant origin. Gonzalez and Vidaver compared strains of clinical and plant origin for bacteriocin production, onion maceration, and plasmid content (11) . McKevitt and Woods studied clinical isolates from cystic fibrosis patients for the presence of virulence factors and plasmids; only 11 of 48 strains in their study possessed one or more plasmids (19) . Certain strains of P. cepacia have been noted to use penicillin or octopine as sole carbon and energy sources; however, no correlation to the presence of plasmid DNA was found (1, 19a) . Only two groups have assigned possible resistance traits to plasmids in P. cepacia (13, 25) . In general, the plasmids in the species are considered cryptic.
More-extensive analyses of plasmids of P. cepacia have been hindered by problems in extraction by standard methods. Both Hirai et al. (13) and Williams et al. (25) reported difficulties in plasmid isolation. Williams et al. (26) suggested that nucleases active in EDTA or sodium dodecyl sulfate (SDS) at the concentrations used in plasmid extraction procedures were responsible for irreproducible plasmid profiles.
In our initial experiments we also encountered difficulties in plasmid isolation from many of the strains included in this study. Selection and modification of some commonly employed extraction methods coupled with optimization of growth conditions led to a procedure that yielded consistent, discrete results with all 37 strains of P. cepacia included in this study. The Plasmid isolation. Plasmid DNA was isolated by a method based on the rapid alkaline extraction method of Birnboim (la) . The 2.7, and 2.1 kb. The method of isolation was as described by Birnboim (la) except for the addition of a phenol-chloroform extraction step. DNA characterization. DNA for both plasmid profiles and restriction digest analyses was separated on 0.7% agarose gels in TBE buffer (89 mM Tris-borate, 89 mM boric acid, 2 mM EDTA). Restriction enzyme digests were done according to standard methods (17) .
Antimicrobial susceptibility tests. Antimicrobial susceptibility was assessed by an agar diffusion method. The antimicrobial agents tested and concentrations per disc were as follows: carbenicillin, 100 ,ug; chloramphenicol, 30 pxg; erythromycin, 15 Conjugation studies. Descriptions of the P. aeruginosa strains and the plasmids employed for conjugation studies are listed in Table 2 . Conjugative transfer of plasmid DNA from P. aeruginosa to P. cepacia and from one P. cepacia strain, WR#3-C4, to other P. cepacia strains was achieved by the solid surface mating technique as described by Bradley et al. (2) . The P. aeruginosa strains were sensitive to polymyxin B. For crosses between P. aeruginosa PA0303/R751 and P. cepacia strains, the transconjugantselective medium contained polymyxin B (300 U/ml) and trimethoprim (200 ,ug/ml). For crosses between P. aeruginosa PU 21/pMG-1 or PU 21/Rip 64 and P. cepacia strains, the selective medium contained HgCl2 (50 ,ug/ml) and polymyxin B (300 U/ml). For crosses between P. cepacia WR#3-C4/R751 and other P. cepacia strains, the selective medium contained neomycin sulfate (50 jxg/ml) and trimethoprim (200 ,ug/ml). Maintenance of the R751 plasmid in P. cepacia transconjugants was determined by periodic culture analysis using gel electrophoresis and growth on trimethoprim agar.
RESULTS
Plasmid profile. Table 1 lists the incidence and sizes of plasmids found among the strains. Plasmids were isolated from 84% of the strains tested, and the incidence of plasmid carriage was high in all groups (clinical strains, 14 of 16; pharmaceutical group, 11 of 13; environmental strains, 6 of 8). A common feature of the species was the presence of large plasmids. Of the 31 strains with plasmids, 26 had one of at least 145 kb in size. Figure 1 depicts all of the plasmid sizes that occurred among the clinical strains, which harbored from one to four plasmids ranging in size from 222 to 2.7 kb. The pharmaceutical-industrial group was next in heterogeneity of plasmids carried, although a number of these strains had similar profiles. The environmental strains had little variation in plasmid size, with five of six strains harboring plasmids of 208 to 212 kb. Strain 4G9 had smaller plasmids of 48 and 2.7 kb. A plasmid of about 48 kb also occurred in environmental strain 7434.
Restriction endonuclease studies. Restriction digests of similarly sized plasmids were compared among the three groups. The environmental isolates had a number of strains with plasmids ranging in size from 208 to 212 kb, resembling similarly sized plasmids in pharmaceutical strains EL-Si, EL-S2, EL-S3, and EL-S4. EL-S3 and EL-S4 had two small plasmids that were not cut in any of the digest studies. The PstI digest (Fig. 2) shows the close relationship among the four environmental strains. The digest of strain 64-22 (lane 2, Fig. 2 ) had the most dissimilar pattern among the environmental class, but its close relationship to the other three strains can be discerned. The PstI digest of the 212-kb plasmids from the product (pharmaceutical) isolates (lanes 6 and 7, Fig. 2 ) resulted in a pattern with only a minimal similarity to the environmental group; however, the two pharmaceutical isolates showed patterns virtually identical to each other (Fig. 2) as well as to those of the other two pharmaceutical strains (EL-Si and EL-S4; data not shown).
Digestion with PvuII yielded the same relationships among the strains (data not shown). The PstI digests of the 157-kb plasmids from clinical strains C-393, WR#3, and WR#3-C4 are compared with that of the 146-kb plasmid from C-175 in Fig. 3 . WR#3 and the antibiotic-sensitive clone WR#3-C4 derived from it produced indistinguishable digest patterns (lanes 1 and 2, Fig. 3 ), whereas those for the plasmids from C-175 and C-393 were quite distinct from each other as well as from those for plasmids from the other strains (lanes 3 and 4, Fig. 3 ).
EcoRI and PvuII restriction digests of 222-kb plasmids that occurred in 12 of the strains (Table 1) were also compared. Six of these strains were of clinical origin, and six were of pharmaceutical origin. All 12 digests made with each restriction enzyme showed similar, if not identical, patterns (data not shown).
Antimicrobial susceptibility. As is typical of P. cepacia, all strains were resistant to polymyxin B. Normally, this species is sensitive to sulfamethoxazole-trimethoprim and chloramphenicol. Strain EL-1 showed a high degree of resistance to most antibiotics tested and was the only strain resistant to sulfamethoxazole-trimethoprim. Several other strains (C-175, EL-2, EL-D6, EL-S5, EL-S6, EL-D4, and EL-D5) in addition to EL-1 were resistant to chloramphenicol. The Table 3 . EcoRI digests of plasmid DNA from the intraspecies transconjugant 17759 and from the interspecies transconjugant EL-D7 were compared with that of R751 from P. aeruginosa (Fig. 4) . The restriction fragment patterns were indistinguishable in all cases. The transconjugants acquired both the trimethoprim resistance trait characteristic of plasmid R751 and a plasmid identical in size and in EcoRI restriction digest profile. There was no observed conjugation between P. aeruginosa harboring either pMG-1 or Rip 64 and P. cepacia.
DISCUSSION
As had been reported by others (13, 25, 26) , we also encountered difficulties in plasmid isolation from P. cepacia using standard methodology. Initially the Kado and Liiu (14) procedure was used for plasmid extraction, but the results were not consistent. The rapid alkaline extraction procedure of Bimboim (la) was used with more success. The plasmids from some strains were isolated with little modification to the method, while others consistently remained recalcitrant and smeared on the gels. The procedure was therefore modified by the addition of a phenol-chloroform extraction step. In addition, several minor changes were made, including increasing the concentration of lysozyme and lengthening the time of treatment with alkaline SDS. Besides extraction procedure changes it was observed that better results were obtained if growth was not to saturation. This was suggested because plasmid isolation from slow-growing strains (e.g., EL-S6 and EL-D6) always yielded discrete bands whereas some of the faster-growing strains gave less-reproducible results. Therefore, the method was adjusted by extracting from overnight cultures with optical densities at 540 nm of <0.7. For nonpseudomonads this was not an important factor; the E. coli and Shigella marker strains could be grown to saturation with reproducible plasmid isolation. The method employed in this study has since been used on a group of Enterobacter strains with excellent results (14a) . Other modifications that were tested included the addition of proteinase K or diethylpyrocarbonate or both, but no enhancement in plasmid isolation was noted, suggesting that nucleases are not responsible for the isolation difficulties experienced with P. cepacia plasmids, as had been suggested (26) .
In this study, 31 of 37 strains or 84% harbored at least one plasmid. Gonzalez and Vidaver (11) (25) . In contrast to the environmental group, the clinical isolates varied considerably in the number and sizes of harbored plasmids. Although the pharmaceutical isolates were not quite as varied in plasmiid species as the clinical isolates, there were obvious similarities between the two. These two groups had the higher-resistance phenotypes, and six of the pharmaceutical isolates and six of the clinical isolates had in common a large plasmid of 222 kb. Another four strains of pharmaceutical origin had large plasmids of similar size (212 kb; Table 1 ), but only two members of this group harbored small plasmids.
Restriction digest analyses showed that the 222-kb plasmids from both clinical and pharmaceutical strains had essentially identical profiles, suggesting a common origin and a widespread occurrence of this plasmid in nature. In fact, pharmaceutical-industrial strains possessing this plasmid were obtained from three different types of products, one manufactured in Puerto Rico and the other two manufactured in the northeastern United States.
In the environmental group, strains 64-22, 25416, 30, and 10856 are all onion isolates. The similarity of their restriction profiles can probably be traced to a common origin. All of the environmental strains produce yellow colonies on agar, as do four of the pharmaceutical isolates (EL-Si, EL-S2, EL-S4, and EL-3) but only one clinical strain (C-175). Gilardi (9) The ability of P. cepacia to accept foreign DNA by conjugative transfer was shown in this study. Plasmid R751 was transferred from P. aeruginosa to several P. cepacia strains. The WR#3-C4 transconjugant was used as the donor to transfer R751 to other P. cepacia strains because it was antibiotic sensitive and it had a resident plasmid that might be mobilized by R751. However, mobilization and subsequent acquisition of this resident plasmid were not observed.
All three groups of P. cepacia strains employed in this study accepted the R751 plasmid by conjugation. The acquired plasmid was indistinguishable from the one donated, as shown by mobility in gel electrophoresis and restriction endonuclease digests. The only phenotypic marker on R751 is for trimethoprim resistance, and all of the P. cepacia strains in this study except for EL-1 were initially sensitive to this compound. The transconjugants all were converted to trimethoprim resistance and were shown to have maintained the plasmid and the resistant phenotype while being held on pyruvate maintenance medium at room temperature for over 6 months. This experimental evidence supports the likelihood of plasmid transfer in this species in nature.
The transfer of trimethoprim resistance among P. cepacia strains is of concern since this antibiotic is one of the few that are generally effective against this species. Since antimicrobial resistance, metabolic diversity, and the ability to survive in a minimal nutrient environment, including purified water systems, are well documented in this species, conjugative transfer of genetic information may increase the instances of product contamination and human infection by this opportunistic bacterium.
